Nissan Chemical Corporation
Notice Regarding Partial Revision of Performance-Linked Stock Compensation Plan
A resolution has been made to revise the performance-linked stock compensation plan for directors and others, proposing to the shareholders' meeting on June 25, 2026, an increase in the upper limit of granted points to 162,700 points per fiscal year (of which 51,100 points are for directors), and raising the upper limit of trust contribution amounts to 2.5 billion yen per applicable period (of which 785 million yen is for directors).
Key Figures
- Upper limit of granted points: 162,700 points (51,100 points for directors)
- Upper limit of trust contribution amount: 2.5 billion yen (785 million yen for directors)
- Upper limit of acquired shares: 488,100 shares (153,300 shares for directors)
AI要約
Overview of Revision to the Performance-Linked Stock Compensation Plan
Nissan Chemical Corporation has resolved to partially revise the performance-linked stock compensation plan “Share Grant Trust (BBT)” for directors (excluding outside directors), executive officers, and corporate auditors. The purpose of the revision is to enhance the linkage between compensation, performance, and stock price, thereby contributing to the medium- to long-term enhancement of corporate value while sharing risks with shareholders. Specifically, the stock compensation ratio will be increased, and the upper limits for granted points and trust contribution amounts will be raised. Performance evaluation criteria will also be revised, changing to metrics such as ROE and a three-year TSR comparison.
Mechanism of the Plan and Future Actions
Under this plan, the company contributes cash to a trust, which acquires company shares and grants stock to directors and others upon their retirement. After revision, the upper limit of granted points per fiscal year will be 162,700 points (51,100 points for directors), and the upper limit of trust contributions will be increased to 2.5 billion yen (785 million yen for directors) per applicable period. Voting rights will not be exercised based on instructions from the trust administrator to ensure neutrality. The revision will be implemented subject to approval at the shareholders' meeting scheduled for June 25, 2026.
Nissan Chemical Corporation
Company overview · Stock price · Financial data · All IR